Introduction

The ETH Zürich offers a curriculum in Pharmaceutical Sciences based on the „Bologna Model“. The first study grade leads to a Bachelor degree, the second to a Master degree either in Pharmaceutical Sciences or in Medicinal and Industrial Pharmaceutical Sciences.

Graduate education leading to the Master degree in Medicinal and Industrial Pharmaceutical Sciences (MIPS) provides a specialized pharmaceutical training with a focus on the various aspects of safe medicinal products development, starting from drug discovery through all stages to market introduction including life-cycle management.

Graduates are especially qualified to work in pharmaceutical research in academia or in the pharmaceutical industry in a leading position, in private organizations dealing with clinical trials or registration documentation, as well as in regulatory authorities to ensure the safe use of medicinal products and medical devices.

The purpose of this Master degree program is to provide graduate level education in the most relevant interacting areas of medicinal and industrial pharmaceutical sciences. The teaching is aimed at covering the most important aspects from conception to safe use of new medicinal products and medical devices.

Upon completion, graduates will have acquired:

• a high level of understanding of the progression of medicinal research and product development from an industrial, regulatory and academic perspective, including the appreciation of, e.g., diseases and potential targets, drug finding, pre-formulation and formulation, preclinical and clinical research and development, production, quality and safety aspects, registration, marketing and life-cycle management.
• a good understanding and hands-on experience of procedures that enable and facilitate the aforementioned medicinal product development, including, e.g., professional communication with adequate technical vocabulary, project management, information and documentation progression, product life cycle management, and ethical aspects.